Interest Medical OÜ
Bankrupt Registry code 12574545
OÜ Tallinn Registered 25 Nov 2013
Interest Medical OÜ is a OÜ based in Tallinn, registry code 12574545, status: bankrupt. Main activity: Wholesale of medicines and other pharmacy goods. According to EMTA, turnover for Q3 2026 was €0 with employees.
Turnover
0 €
State taxes
—
Labour taxes
—
Employees
—
Q3 2026 · data from the Tax and Customs Board (EMTA)
Position in the industry
- Revenue · 2023 4 mn €above 92% of companiesindustry median 63 715 € · companies in the industry: 10 708
- Net profit margin · 2023 -26.1 %above 9% of companiesindustry median 3.5 % · companies in the industry: 7 928
Taxes and turnover
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Quarter | Turnover, € | State taxes, € | Labour taxes, € | Employees |
|---|---|---|---|---|
| Q3 2026 | — | — | — | — |
| Q2 2026 | — | — | — | — |
| Q1 2026 | — | 859 | 920 | 2 |
| Q4 2025 | — | 10 294 | 11 026 | 2 |
| Q3 2025 | — | 1 262 | 1 743 | 1 |
| Q2 2025 | 2 262 | 4 260 | 5 322 | 3 |
| Q1 2025 | 5 720 | 6 152 | 6 794 | 3 |
| Q4 2024 | 3 813 | 5 529 | 7 024 | 3 |
| Q3 2024 | 3 752 | 5 367 | 7 173 | 3 |
| Q2 2024 | 5 570 | 7 760 | 7 489 | 3 |
| Q1 2024 | 6 857 | 10 628 | 11 260 | 3 |
| Q4 2023 | 1 803 | 27 286 | 27 885 | 5 |
| Q3 2023 | 11 456 | 12 119 | 13 235 | 6 |
| Q2 2023 | 11 894 | 16 860 | 17 966 | 6 |
| Q1 2023 | 9 886 | 17 883 | 18 658 | 6 |
| Q4 2022 | 41 420 | 21 892 | 21 223 | 6 |
| Q3 2022 | 636 940 | 20 038 | 21 223 | 6 |
| Q2 2022 | 166 919 | 16 032 | 16 918 | 6 |
| Q1 2022 | 1 273 189 | 23 808 | 22 525 | 5 |
Financials by year
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
- Company
- Industry median
Industry: Wholesale trade (the EMTAK division of the main activity). Median: half of the industry is above, half below.
| Year | Revenue, € | Net profit, € | Labour costs, € | Assets, € | Equity, € | Employees |
|---|---|---|---|---|---|---|
| 2023 | 4 000 424 | -1 046 091 | 237 215 | 4 478 271 | 2 120 312 | 5 |
| 2022 | 1 669 480 | -264 856 | 248 109 | 3 402 704 | 3 166 403 | 7 |
| 2021 | 3 919 973 | 2 297 | 339 887 | 4 065 696 | 3 431 259 | 11 |
| 2020 | 4 656 615 | 99 885 | 329 018 | 3 586 502 | 3 428 962 | 12 |
| 2019 | 6 723 044 | 802 963 | 359 159 | 3 410 589 | 3 329 077 | 13 |
| 2018 | — | — | — | — | — | 14 |
| 2017 | — | — | — | — | — | 8 |
| 2016 | — | — | — | — | — | 2 |
| 2015 | — | — | — | — | — | 1 |
| 2014 | — | — | — | — | — | 0 |
Figures from the company’s own (non-consolidated) balance sheet and income statement. A loss is shown with a minus sign.
Financial ratios for 2023
Net profit margin
-26.1 %
Net profit / revenue
Return on equity (ROE)
-49.3 %
Net profit / equity
Return on assets (ROA)
-23.4 %
Net profit / assets
Equity ratio
47.3 %
Equity / assets
Debt ratio
52.7 %
Liabilities / assets
Current ratio
1.36
Current assets / current liabilities
Revenue per employee
800 360 €
Revenue / average full-time employees
Labour cost per employee per month
3 954 €
Labour costs / employees / 12 months (incl. employer taxes)
Annual reports
| Year | Period | Filed | Report | Documents |
|---|---|---|---|---|
| 2023 | 1 Jan 2023 – 31 Dec 2023 | 30 Jun 2024 | Company’s own · audited | e-Äriregister |
| 2022 | 1 Jan 2022 – 31 Dec 2022 | 30 Jun 2023 | Company’s own · audited | e-Äriregister |
| 2021 | 1 Jan 2021 – 31 Dec 2021 | 21 Feb 2023 | Company’s own · audited | e-Äriregister |
| 2020 | 1 Jan 2020 – 31 Dec 2020 | 6 Aug 2021 | Company’s own · audited | e-Äriregister |
| 2019 | 1 Jan 2019 – 31 Dec 2019 | 30 Jun 2020 | Company’s own · audited | e-Äriregister |
Board
- Oleksandr ShliakhovBoard member · since 7 Nov 2025
- Indrek LepsooBankruptcy trustee · since 24 Apr 2026
Right of representation
Any member of the management board may represent the private limited company in all transactions.
Owners
- Oleksandr ShliakhovNatural person · 2 500 €
Beneficial owners
- Oleksandr ShliakhovDirect ownership · UKR · since 13 Nov 2025
Founders and other persons
- Valeri TrofimovFounder · 2 500 € · 24 Nov 2013
Related companies
Activities (EMTAK)
- 46461Wholesale of medicines and other pharmacy goods Main
History of changes
| What | Value | Period |
|---|---|---|
| Status | Bankrupt | 24 Apr 2026 – now |
| Status | Active | 25 Nov 2013 – now |
Rulings
All rulings (PDF)| Number, date | Title | Deadline | State | Document |
|---|---|---|---|---|
| Ä 10190118 / 24 24 Apr 2026 |
Bankruptcy declared | In force 24 Apr 2026 |
||
| Ä 10190118 / 23 7 Nov 2025 |
Amendment entry | In force 7 Nov 2025 |
||
| Ä 10190118 / 22 4 Nov 2025 |
Amendment entry | In force 4 Nov 2025 |
||
| Ä 10190118 / 21 15 Apr 2025 |
Amendment entry | In force 15 Apr 2025 |
||
| Ä 10190118 / 20 8 Jul 2024 |
Amendment entry | In force 8 Jul 2024 |
||
| Ä 10190118 / 19 2 Jul 2024 |
Amendment entry | In force 2 Jul 2024 |
||
| Ä 10190118 / 18 18 Oct 2023 |
Amendment entry | In force 18 Oct 2023 |
||
| Ä 10190118 / 17 10 Oct 2023 |
Amendment entry | In force 10 Oct 2023 |
||
| Ä 10190118 / 16 2 Sep 2023 |
Amendment entry | In force 2 Sep 2023 |
||
| Ä 10190118 / 15 6 Feb 2023 |
Amendment entry | In force 6 Feb 2023 |
||
| Ä 10190118 / M4 26 Jan 2023 |
Ruling to eliminate deficiencies | 25 Feb 2023 | Deficiencies eliminated 6 Feb 2023 |
|
| Ä 10190118 / 14 20 Dec 2022 |
Entry refused: deficiencies not eliminated | In force 23 Jan 2023 |
||
| Ä 10190118 / M3 28 Nov 2022 |
Ruling to eliminate deficiencies | 18 Dec 2022 | In force 28 Nov 2022 |
|
| Ä 10190118 / 13 8 Nov 2022 |
Amendment under Commercial Code § 525 (2) | In force 8 Nov 2022 |
||
| Ä 10190118 / 12 15 Aug 2019 |
Amendment entry | In force 15 Aug 2019 |
||
| Ä 10190118 / 11 29 Mar 2019 |
Amendment under Commercial Code § 525 (2) | In force 29 Mar 2019 |
||
| Ä 10190118 / 10 28 Jun 2018 |
Amendment entry | In force 28 Jun 2018 |
||
| Ä 10190118 / M2 8 Jun 2018 |
Ruling to eliminate deficiencies | 23 Jun 2018 | Deficiencies eliminated 8 Jun 2018 |
|
| Ä 10190118 / 9 8 Jun 2018 |
Amendment entry | In force 8 Jun 2018 |
||
| Ä 10190118 / 8 6 Jun 2018 |
Amendment entry | In force 6 Jun 2018 |
||
| Ä 10190118 / 7 14 May 2018 |
Amendment under Commercial Code § 525 (2) | In force 14 May 2018 |
||
| Ä 10190118 / 6 19 Jan 2018 |
Amendment entry | In force 19 Jan 2018 |
||
| Ä 10190118 / 5 6 Dec 2017 |
Amendment entry | In force 6 Dec 2017 |
||
| Ä 10190118 / 4 29 Sep 2016 |
Amendment entry | In force 29 Sep 2016 |
||
| Ä 10190118 / 3 16 Sep 2016 |
Amendment entry | In force 16 Sep 2016 |
||
| Ä 10190118 / 2 13 Mar 2014 |
Amendment entry | In force 13 Mar 2014 |
||
| Ä 10190118 / M1 11 Mar 2014 |
Ruling to eliminate deficiencies | 31 Mar 2014 | Deficiencies eliminated 13 Mar 2014 |
|
| Ä 10190118 25 Nov 2013 |
First entry | In force 25 Nov 2013 |
Sources: e-Äriregister and EMTA. Data updated 1 Nov 2026. Open at the source ↗ · Report an error in the data